Malvina N Skorska, Pongpun Saokhieo, Lindsey T Thurston, Lindsay A Coome, Oranitcha Kaewthip, Suwat Chariyalertsak, Doug P VanderLaan
{"title":"外源性激素在泰国清迈跨性别个体中的使用","authors":"Malvina N Skorska, Pongpun Saokhieo, Lindsey T Thurston, Lindsay A Coome, Oranitcha Kaewthip, Suwat Chariyalertsak, Doug P VanderLaan","doi":"10.1089/trgh.2022.0087","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study describes Thai transfeminine individuals' exogenous hormone use.</p><p><strong>Methods: </strong>During the period May-July 2017, a survey was conducted among Thai transfeminine adults (<i>N</i>=181) who reported their exogenous hormone use, age at onset of use, brands used, where they obtained hormones, and discontinuation of use.</p><p><strong>Results: </strong>Most participants (86.74%) used exogenous hormones. The mean (standard deviation) age of onset of use was 16.59 (3.79) years. A range of 1-15 brands with varying chemical composition were used. Hormones were typically procured from pharmacies (91.39%) and seldom physician prescribed (8.61%). Discontinuing use for 6 or more months was common (59.62%).</p><p><strong>Conclusions: </strong>Gender-affirming health care beginning in adolescence for Thai transfeminine individuals is needed.</p>","PeriodicalId":37265,"journal":{"name":"Transgender Health","volume":" ","pages":"516-521"},"PeriodicalIF":2.0000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669632/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exogenous Hormone Use Among Transfeminine Individuals in Chiang Mai, Thailand.\",\"authors\":\"Malvina N Skorska, Pongpun Saokhieo, Lindsey T Thurston, Lindsay A Coome, Oranitcha Kaewthip, Suwat Chariyalertsak, Doug P VanderLaan\",\"doi\":\"10.1089/trgh.2022.0087\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study describes Thai transfeminine individuals' exogenous hormone use.</p><p><strong>Methods: </strong>During the period May-July 2017, a survey was conducted among Thai transfeminine adults (<i>N</i>=181) who reported their exogenous hormone use, age at onset of use, brands used, where they obtained hormones, and discontinuation of use.</p><p><strong>Results: </strong>Most participants (86.74%) used exogenous hormones. The mean (standard deviation) age of onset of use was 16.59 (3.79) years. A range of 1-15 brands with varying chemical composition were used. Hormones were typically procured from pharmacies (91.39%) and seldom physician prescribed (8.61%). Discontinuing use for 6 or more months was common (59.62%).</p><p><strong>Conclusions: </strong>Gender-affirming health care beginning in adolescence for Thai transfeminine individuals is needed.</p>\",\"PeriodicalId\":37265,\"journal\":{\"name\":\"Transgender Health\",\"volume\":\" \",\"pages\":\"516-521\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-12-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669632/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transgender Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/trgh.2022.0087\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Social Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transgender Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/trgh.2022.0087","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Social Sciences","Score":null,"Total":0}
Exogenous Hormone Use Among Transfeminine Individuals in Chiang Mai, Thailand.
Purpose: This study describes Thai transfeminine individuals' exogenous hormone use.
Methods: During the period May-July 2017, a survey was conducted among Thai transfeminine adults (N=181) who reported their exogenous hormone use, age at onset of use, brands used, where they obtained hormones, and discontinuation of use.
Results: Most participants (86.74%) used exogenous hormones. The mean (standard deviation) age of onset of use was 16.59 (3.79) years. A range of 1-15 brands with varying chemical composition were used. Hormones were typically procured from pharmacies (91.39%) and seldom physician prescribed (8.61%). Discontinuing use for 6 or more months was common (59.62%).
Conclusions: Gender-affirming health care beginning in adolescence for Thai transfeminine individuals is needed.